Reference Citation Analysis: Find an Article, Find a Category, Find a Journal, Find a Scholar

For: Wong KM, Capasso A, Eckhardt SG. The changing landscape of phase I trials in oncology. Am Soc Clin Oncol Educ Book 2015:3-8. [PMID: 25993134 DOI: 10.14694/edbook_am.2015.35.3] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 06/04/2023]

For:	Wong KM, Capasso A, Eckhardt SG. The changing landscape of phase I trials in oncology. Am Soc Clin Oncol Educ Book 2015:3-8. [PMID: 25993134 DOI: 10.14694/edbook_am.2015.35.3] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 06/04/2023]

Number	Cited by Other Article(s)
1	Corbaux P, El-Madani M, Tod M, Péron J, Maillet D, Lopez J, Freyer G, You B. Clinical efficacy of the optimal biological dose in early-phase trials of anti-cancer targeted therapies. Eur J Cancer 2019;120:40-46. [DOI: 10.1016/j.ejca.2019.08.002] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/04/2019] [Revised: 07/26/2019] [Accepted: 08/02/2019] [Indexed: 10/26/2022] Abstract Collapse Key Words Collapse MESH Headings Collapse Grants Collapse Affiliation(s) Collapse

Number

Cited by Other Article(s)

Corbaux P, El-Madani M, Tod M, Péron J, Maillet D, Lopez J, Freyer G, You B. Clinical efficacy of the optimal biological dose in early-phase trials of anti-cancer targeted therapies. Eur J Cancer 2019;120:40-46. [DOI: 10.1016/j.ejca.2019.08.002] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/04/2019] [Revised: 07/26/2019] [Accepted: 08/02/2019] [Indexed: 10/26/2022]